TokenPost·
Emergent BioSolutions Projects 2026 Revenue of $600 Million to $645 Million
The company raised its adjusted gross margin outlook to 45%-47% and expects adjusted EBITDA of $110 million to $140 million.
More news
- TokenPostTsakos Board Declares $0.578125 Dividend on Series E Preferred Shares
- TokenPostPetrus Resources Sets Nov. 27 Payment for $0.01 Monthly Dividend
- TokenPostPaycom Declares $0.375 Quarterly Cash Dividend for Dec. 7 Payment
- Bitcoin.com NewsThai Police Get Shuffle Crypto Casino Money-Trail Data From 3 Exchanges
- TokenPostMidland States Sets $0.4844 Dividend Per Series A Depositary Share
- TokenPostWatts Water Technologies Declares $0.63 Quarterly Dividend